Literature DB >> 2850910

Antibiotic uptake into gram-negative bacteria.

R E Hancock1, A Bell.   

Abstract

Antibiotics taken up into gram-negative bacteria face two major diffusion barriers, the outer and cytoplasmic membranes. Of these, the former has been most studied and is discussed in detail here. Evidence from antibiotic MIC studies on porin-deficient mutants compared with their porin-sufficient parent strains has provided strong support for the proposal that some antibiotics, particularly beta-lactams, pass across the outer membrane through the water-filled channels of a class of proteins called porins. Nevertheless substantial evidence has accumulated for the importance of non-porin pathways of antibiotic uptake across the outer membranes of gram-negative bacteria. Examples discussed include the uptake of polycationic antibiotics via the self-promoted pathway, the uptake of hydrophobic antibiotics in some bacterial species and in mutants of others via the hydrophobic pathway, and the possible importance of poorly understood non-porin pathways of uptake of a variety of antibiotics. Other potential barriers to diffusion, including the cytoplasmic membrane, are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850910     DOI: 10.1007/bf01975036

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

Review 1.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

2.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system.

Authors:  N A Watanabe; T Nagasu; K Katsu; K Kitoh
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 4.  On the mechanism of translocation of dihydrostreptomycin across the bacterial cytoplasmic membrane.

Authors:  W W Nichols
Journal:  Biochim Biophys Acta       Date:  1987

5.  The effect of lipopolysaccharide on lipid bilayer permeability of beta-lactam antibiotics.

Authors:  R Hiruma; A Yamaguchi; T Sawai
Journal:  FEBS Lett       Date:  1984-05-21       Impact factor: 4.124

Review 6.  Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

7.  Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin.

Authors:  K J Harder; H Nikaido; M Matsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

8.  Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.

Authors:  R A Moore; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

9.  Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant.

Authors:  T I Nicas; R E Hancock
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

10.  Mapping and characterization of two mutations to antibiotic supersusceptibility in Pseudomonas aeruginosa.

Authors:  B L Angus; J A Fyfe; R E Hancock
Journal:  J Gen Microbiol       Date:  1987-10
View more
  68 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  Photodynamic therapy with fullerenes in vivo: reality or a dream?

Authors:  Sulbha K Sharma; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2011-12       Impact factor: 5.307

4.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria.

Authors:  J Barrett Deris; Minsu Kim; Zhongge Zhang; Hiroyuki Okano; Rutger Hermsen; Alexander Groisman; Terence Hwa
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

6.  Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria.

Authors:  Liam Berry; Ronald Domalaon; Marc Brizuela; George G Zhanel; Frank Schweizer
Journal:  Medchemcomm       Date:  2019-03-07       Impact factor: 3.597

Review 7.  Can light-based approaches overcome antimicrobial resistance?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Drug Dev Res       Date:  2018-08-02       Impact factor: 4.360

8.  Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa.

Authors:  Thilo Köhler; Jean-Luc Dumas; Christian Van Delden
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

9.  Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.

Authors:  J L Kadurugamuwa; J S Lam; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Rhamnolipid stimulates uptake of hydrophobic compounds by Pseudomonas aeruginosa.

Authors:  Wouter H Noordman; Dick B Janssen
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.